首页> 外文期刊>Nature >The Lkb1 metabolic sensor maintains haematopoietic stem cell survival
【24h】

The Lkb1 metabolic sensor maintains haematopoietic stem cell survival

机译:Lkb1代谢传感器维持造血干细胞存活

获取原文
获取原文并翻译 | 示例
       

摘要

Haematopoietic stem cells (HSCs) can convert between growth states that have marked differences in bioenergetic needs. Although often quiescent in adults, these cells become proliferative upon physiological demand. Balancing HSC energetics in response to nutrient availability and growth state is poorly understood, yet essential for the dynamism of the haematopoietic system. Here we show that the Lkbl tumour suppressor is critical for the maintenance of energy homeostasis in haematopoietic cells. Lkbl inactivation in adult mice causes loss of HSC quiescence followed by rapid depletion of all haematopoietic subpopulations. Lkbl -deficient bone marrow cells exhibit mitochondrial defects, alterations in lipid and nucleotide metabolism, and depletion of cellular ATP. The haematopoietic effects are largely independent of Lkbl regulation of AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) signalling. Instead, these data define a central role for Lkbl in restricting HSC entry into cell cycle and in broadly maintaining energy homeostasis in haematopoietic cells through a novel metabolic checkpoint.
机译:造血干细胞(HSC)可以在生物能需求明显不同的生长状态之间转换。尽管这些细胞通常在成年人中处于静止状态,但在生理需要时它们会增殖。平衡HSC能量以响应养分的可利用性和生长状态的了解很少,但对于造血系统的动力至关重要。在这里,我们显示Lkbl肿瘤抑制器对于维持造血细胞能量稳态至关重要。成年小鼠中的Lkb1失活会导致HSC静止性丧失,然后迅速耗尽所有造血亚群。 Lkb1缺乏的骨髓细胞表现出线粒体缺陷,脂质和核苷酸代谢的改变以及细胞ATP的消耗。造血作用在很大程度上独立于AMP激活的蛋白激酶(AMPK)的Lkb1调节和雷帕霉素(mTOR)信号转导的哺乳动物靶标。相反,这些数据在限制HSC进入细胞周期并通过新的代谢检查点广泛维持造血细胞的能量稳态方面,为Lkbl发挥了核心作用。

著录项

  • 来源
    《Nature》 |2010年第7324期|p.659-663|共5页
  • 作者单位

    Cancer Center and Center for Regenerative Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA;

    rnCancer Center and Center for Regenerative Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA,Harvard Stem Cell Institute and Department of Stem Cell and Regenerative Biology, Harvard University, Boston, Massachusetts 02115, USA;

    rnCancer Center and Center for Regenerative Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA;

    rnCancer Center and Center for Regenerative Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA;

    rnCancer Center and Center for Regenerative Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA,Harvard Stem Cell Institute and Department of Stem Cell and Regenerative Biology, Harvard University, Boston, Massachusetts 02115, USA;

    rnCancer Center and Center for Regenerative Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA,Harvard Stem Cell Institute and Department of Stem Cell and Regenerative Biology, Harvard University, Boston, Massachusetts 02115, USA;

    rnCancer Center and Center for Regenerative Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA;

    rnHelicosBioSciences Corporation, Cambridge, Massachusetts 02139, USA;

    rnHelicosBioSciences Corporation, Cambridge, Massachusetts 02139, USA;

    rnCenter for Biomedical Informatics and Informatics Program, Children's Hospital, and Harvard Medical School, Boston, Massachusetts 02115, USA.;

    rnCenter for Biomedical Informatics and Informatics Program, Children's Hospital, and Harvard Medical School, Boston, Massachusetts 02115, USA.;

    rnDepartment of Medicine, Evans Research Center, Mitochondria ARC, Boston University Medical Center, Boston, Massachusetts 02118, USA;

    rnCancer Center and Center for Regenerative Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA,Harvard Stem Cell Institute and Department of Stem Cell and Regenerative Biology, Harvard University, Boston, Massachusetts 02115, USA;

    rnCancer Center and Center for Regenerative Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 02:55:22

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号